Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer

NCT05444998 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Intuzumab, pyrrolidone, nab-paclitaxel

Sponsor

Xijing Hospital